CVS Health stock costs EUR 76.14 as revenue grew 7.30 percent
Published on 10/01/2026 at 14:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVS Health Corp. (ISIN US1266501006) was trading at EUR 76.14 at Lang & Schwarz on October 1, 2026 at 2:36 p.m. CEST, while second-quarter 2026 revenue grew 7.30 percent year over year. The latest results also included adjusted earnings per share of USD 2.58 versus USD 1.87 consensus, according to MarketBeat on September 20, 2026.
Revenue reaches USD 106.10 billion
The second-quarter revenue figure was USD 106.10 billion, compared with analyst estimates of USD 100.03 billion. The USD 6.07 billion gap shows that the quarter delivered more than revenue growth alone, with sales exceeding the consensus benchmark by 6.07 percent.
Adjusted earnings per share of USD 2.58 also exceeded the USD 1.87 consensus by USD 0.71. Yahoo Finance reported on September 4, 2026 that the company raised full-year adjusted earnings guidance to USD 7.90-8.10 from USD 7.30-7.50.
Guidance adds an earnings benchmark
The guidance range implies a USD 0.60 increase at both ends versus the earlier outlook. CVS also raised its full-year cash flow from operations outlook to at least USD 11.50 billion from at least USD 9.50 billion, giving investors a second operating benchmark alongside earnings.
Analyst sentiment remains measurable rather than unanimous. MarketBeat cited 22 Buy ratings and one Hold rating, with a consensus target of USD 107.24 on September 20, 2026. That target is a separate US-dollar reference and does not replace the euro quote from Lang & Schwarz.
Next report is set for November 4
TradingView lists November 4, 2026 as the next CVS Health earnings date and identifies the expected reporting period as the third quarter of 2026. The company operates through healthcare benefits, health services, pharmacy and consumer wellness, according to CVS Health.
EUR 76.14 quote at Lang & Schwarz
CVS Health was trading at EUR 76.14 at Lang & Schwarz on October 1, 2026 at 2:36 p.m. CEST, up 0.63 percent versus the prior close of EUR 75.66 on September 30, 2026. The primary listing is on the NYSE, where the stock closed at USD 85.69 on September 30, 2026, according to the dated quote context from the company profile.
The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.
CVS Health stock facts
- Company: CVS Health Corp.
- ISIN: US1266501006
- Ticker: CVS
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 1, 2026, 2:36 p.m. CEST): EUR 76.14
- Change versus prior close: plus 0.63 percent
- Prior close Lang & Schwarz (September 30, 2026): EUR 75.66
- Market capitalization: USD 109.3 billion (as of September 30, 2026)
- 52-week range: USD 69.51-110.68 (as of September 30, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
- Next earnings date: November 4, 2026
